Glaucoma therapeutics and diagnostics based on a novel human transcription factor
US6207450A · kind A · utility
4Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 1998 |
| Grant date | Mar 27, 2001 |
| Priority date | — |
| Expiry date | May 22, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions for treating glaucoma and methods and compositions for prognosing or diagnosing glaucoma in a subject are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.